Table 4. Occupational vs. indoor (home) mold-exposed subjects.
| Occupational mold exposure | Indoor (home) mold exposure | |
|---|---|---|
| Number: n | 23 | 13 |
| Extensively exposed: n (%) | 17 (74%) | 6 (46%) |
| Currently exposed: n (%) | 4 (17%) | 5 (39%) |
| Low exposed: n (%) | 2 (9%) | 2 (15%) |
| Respiratory symptoms: n (%) | 23 (100%)* | 10 (77%) |
| Asthma: n (%) | 20 (87%)** | 6 (46%) |
| sx1 IgE ≥ 0.35 (kUA/L): n (%) | 14 (61%) | 10 (77%) |
| sx1 IgE (kUA/L): median (range) | 0.65 (0.03 – 20.48) | 15.62 (0.07 – 150.0)** |
| tIgE ≥ 150 (kU/L): n (%) | 11 (48%) | 8 (62%) |
| tIgE (kU/L): median (range) | 140.8 (3.82 – 2122.0) | 184.4 (18.15 – 4302.0) |
| mx1 IgE ≥ 0.35 (kUA/L): n (%) | 9 (39%) | 5 (39%) |
| mx1 IgE (kUA/L): median (range) | 0.15 (0.02 – 26.31) | 0.08 (0.02 – 16.63) |
| Re-testing of mx1 positive sera | n = 9 | n = 5 |
| Asp f sensitization: n (%) | 9/9 (100%) | 4/5 (80%) |
| Asp f IgE (kUA/L): median (range) | 3.23 (0.93 – 61.63)* | 0.69 (0.06 – 1.82) |
| Pen ch sensitization: n (%) | 5/9 (56%) | 4/5 (80%) |
| Pen ch IgE (kUA/L): median (range) | 0.40 (0.07 – 8.7) | 0.54 (0.04 – 6.21) |
| Alt a sensitization: n (%) | 6/9 (67%) | 5/5 (100%) |
| Alt a IgE (kUA/L): median (range) | 1.12 (0.02 – 15.75) | 1.83 (0.81 – 5.91) |
| Cla h sensitization: n (%) | 3/9 (33%) | 3/5 (60%) |
| Cla h IgE (kUA/L): median (range) | 0.10 (0.02 – 2.02) | 2.73 (0.03 – 18.42) |
| CC16 (ng/mL): median (range) | 6.08 (3.99 – 21.96) | 8.86 (5.29 – 16.16) |
| IL-6 (pg/mL): median (range) | 4.7 (4.7 – 30.20) | 4.7 (4.7 – 73.80) |
| SAA (ng/mL): median (range) | 19,331 (1,880 – 95,488) | 15,475 (3,086 – 578,522) |
Significant differences are bold and labeled with *p ≤ 0.05 and **p ≤ 0.01.